Currently SCT is raising and providing funds to support a number of research projects, these include:
Featured
Although survival is the goal, the impact and cost of cancer doesn’t stop when treatment finishes. Afterwards patients may be less active; have muscle weakness; be at risk of falling or bed bound; or struggle with everyday tasks; and some patients can lose bowel or bladder function.
Treatment of bone tumours and soft tissue sarcomas.
To decrease the risk of infection in order to provide a better outcome and life quality, less morbidity and lower amputation rates for the patients.
Ollier disease / Maffucci syndrome is a rare ‘orphan’ disease affecting less than 100,000 of the population.
Characterised by cartilaginous and vascular tumours - heamangiomas - in the case of Maffucci syndrome.
An exciting new technique that has the potential to revolutionise bone cancer surgery.
Providing the ability to differentiate between healthy and cancerous tissue in real-time.
To decipher genetic codes that form tumours
Research over the last 10 years has led to the identification of new biomarkers which has allowed patients to receive better and safer diagnoses of bone tumours.